Bérénice Leclercq

Bérénice Leclercq

Auto-generated profile, based on publicly available information

Bérénice Leclercq

Univ. Lille, CHU Lille, Institut Pasteur de Lille, EA4483 IMPECS-IMPact de l'Environnement Chimique sur la Santé humaine, France; IMT Lille Douai, Univ. Lille, SAGE-Département Sciences de l'Atmosphère et Génie de l'Environnement, F-59000 Lille, France

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2011 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
NONathalie Ollivier
Nathalie Ollivier
JVJérôme VICOGNE
Jérôme VICOGNE
AVAurélie Vallin
Aurélie Vallin
HDHervé Drobecq
Hervé Drobecq
RDRémi Desmet
Rémi Desmet
OMOleg Melnyk
Oleg Melnyk

1 November 2017 in Environmental Pollution
Verified
Journal Article
Closed access
BLB. Leclercq
B. Leclercq
APA. Platel
A. Platel
SAS. Antherieu
S. Antherieu
LALaurent Alleman
Laurent Alleman
EHE.M. Hardy
E.M. Hardy
Garcon GuillaumeGarcon Guillaume
Garcon Guillaume

1 November 2016 in Environmental Pollution
Verified
Journal Article
Closed access
BLB. Leclercq
B. Leclercq
MHM. Happillon
M. Happillon
SAS. Antherieu
S. Antherieu
EHE.M. Hardy
E.M. Hardy
LALaurent Alleman
Laurent Alleman
Garcon GuillaumeGarcon Guillaume
Garcon Guillaume

1 July 2017 in Environmental Research
Verified
Journal Article
Closed access
BLBérénice Leclercq
Bérénice Leclercq
LALaurent Alleman
Laurent Alleman
EPEsperanza Perdrix
Esperanza Perdrix
VRVéronique Riffault
Véronique Riffault
MHMélanie Happillon
Mélanie Happillon
PCPatrice CODDEVILLE
Patrice CODDEVILLE

30 May 2017 in Chemical Science
Verified
Journal Article
Open access
PDF file
NON. Ollivier
N. Ollivier
RDR. Desmet
R. Desmet
HDH. Drobecq
H. Drobecq
ABA. Blanpain
A. Blanpain
EBE. Boll
E. Boll
OMOleg Melnyk
Oleg Melnyk
We show that the combination of solid phase and solution ligation techniques facilitates the production of a challenging and biologically active protein made of 180 amino acids.

29 January 2015 in Chemical Science
Verified
Journal Article
Open access
PDF file
CSClaire Simonneau
Claire Simonneau
BLBérénice Leclercq
Bérénice Leclercq
AMAlexandra Mougel
Alexandra Mougel
EAEric Adriaenssens
Eric Adriaenssens
CPCharlotte Paquet
Charlotte Paquet
JVJérôme VICOGNE
Jérôme VICOGNE
The development of MET receptor agonists is an important goal in regenerative medicine, but is limited by the complexity and incomplete understanding of its interaction with HGF/SF (Hepatocyte Growth Factor/Scatter Factor). NK1 is a natural occurring agonist comprising the N-terminal (N) and the first kringle (K1) domains of HGF/SF. In the presence of heparin, NK1 can self-associate into a “head to tail” dimer which is considered as the minimal structural module able to trigger MET dimerization and activation whereas isolated K1 and N domains showed a weak or a complete lack of agonistic activity respectively. Starting from these structural and biological observations, we investigated whether it was possible to recapitulate the biological properties of NK1 using a new molecular architecture of isolated N or K1 domains. Therefore, we engineered multivalent N or K1 scaffolds by combining synthetic and homogeneous site-specifically biotinylated N and K1 domains (NB and K1B) and streptavidin (S). NB alone or in complex failed to activate MET signaling and to trigger cellular phenotypes. Importantly and to the contrary of K1B alone, the semi-synthetic K1B/S complex mimicked NK1 MET agonist activity in cell scattering, morphogenesis and survival phenotypic assays. Impressively, K1B/S complex stimulated in vivo angiogenesis and, when injected in mice, protected the liver against fulminant hepatitis in a MET dependent manner whereas NK1 and HGF were substantially less potent. These data reveal that without N domain, proper multimerization of K1 domain is a promising strategy for the rational design of powerful MET agonists.